MRD / Regn No. : THBC\23-24\08558 Date : 30/06/2026
Patient Name : Gulzar Mistry Age & Gender : 73 Yrs. / Male
Contact No. : 9867564117 UHID :
Ht / Wt / BMI : 164 / 84.75 / 31.51 BP S / BP D : 130 / 83
Allergies : NONE Referred By :
   
Problem List : T2DM (31/Mar/2017) |
Subjective : T2DM SINCE 2017,UNDER CHEMOTHERAPY - FIRST 4-5 DAYS ARE DIFFICULT,SKIN DRY / SENSITVITY TO AIR / SOME SKIN ERUPTIONS,RECENT TINGLING IN HANDS
Objective : 27-JUN-2026 REPORTS,UACR-13.12,TC-192/ TG-162/ LDL-114/ HDL-46,ALT-24/ AST-38,HBA1C-5.4%,FBS-90/ PPBS-127
Plan : STOPPING LUPIMEG - CT REST MEDS  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET EVOGLIPTIN
VALERA 5 MG 		ORAL 1-0-0 ABF
 3 MTHS
2 DAPA 10 MG ORAL 1-0-0 ABF
 3 MTHS
3 DIAMICRON XR 60 MG ORAL 1-0-1 BBF/BD
 3 MTHS
4 TABLET TELMISARTAN 40MG
ERITEL 40 MG 		ORAL 1-0-0 ABF
 3 MTHS
       
Refill : 0 / Substitution:    
Education : IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 30/Sep/2026
Tests Suggested For Next Visit : FBS 90-130 / PPBS 140-180 / HBA1C < 6,5% - SAME MEDS,FBS / PPBS MTHLY,HBA1C 3 MTHLY
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: